Dimensional Fund Advisors LP Portage Biotech Inc. Transaction History

Dimensional Fund Advisors LP

  • $363 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
SELL
$1.09 - $2.65 $4,130 - $10,040
-3,789 Reduced 26.4%
10,565 $19,000
Q3 2023

Nov 09, 2023
SELL
$2.09 - $3.68 $5,561 - $9,792
-2,661 Reduced 15.64%
14,354 $29,000
Q1 2023

May 12, 2023
SELL
$2.6 - $7.2 $3,408 - $9,439
-1,311 Reduced 7.15%
17,015 $52,000
Q4 2022

Feb 09, 2023
BUY
$4.42 - $7.44 $11,713 - $19,716
2,650 Added 16.9%
18,326 $96,000
Q3 2022

Nov 10, 2022
BUY
$6.81 - $10.12 $106,753 - $158,641
15,676 New
15,676 $107,000

Others Institutions Holding PRTG

# of Institutions
27
Shares Held
2.16M
Call Options Held
0
Put Options Held
0
View Full List

About PORTAGE BIOTECH INC.

PRTG Quotes by TradingView
  • Ticker PRTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,943,700
  • Market Cap $3.56M
  • Description
  • Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a smal...
More about PRTG
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email